Cargando…
A Case of Acute Heart Failure due to Immune Checkpoint Blocker Nivolumab
Immune checkpoint inhibitors can be potentially cardiotoxic. It has not been frequently reported in the literature. Cardiomyopathy with these agents can have early onset and may start with non-specific symptoms like fatigue, weakness before presenting with obvious features of acute heart failure. Ra...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elmer Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469913/ https://www.ncbi.nlm.nih.gov/pubmed/31019642 http://dx.doi.org/10.14740/cr838 |